Mainga Hamaluba/Front Immunol
R21/Matrix-M malaria vaccine drives diverse immune responses in pre-exposed adults: insights from a phase IIb controlled human malaria infection trial.Kibwana E, Bundi C, Kimani D, Nyamako L, Keter K, Mutiso A, Ogwang R, Bellamy D, Rapi K, Bajer A, Provstgaard-Morys S, Stockdale L, Munoz O, Datoo MS, Lawrie A, Ramos-Lopez F, Roberts R, Hamaluba M, Hill AVS, Bejon P, Ewer KJ, Kapulu M
Front Immunol, (2025). 16:1620365
Vaccine-induced responses to R21/Matrix-M - an analysis of samples from a phase 1b age de-escalation, dose-escalation trial.Bundi C, Bellamy D, Kibwana E, Nyamako L, Ogwang R, Keter K, Kimani D, Salman AM, Provstgaard-Morys S, Stockdale L, Hill AVS, Bejon P, Olotu A, Hamaluba M, Ewer KJ, Kapulu MC
Front Immunol, (2025). 16:1620366
